Tag: PCR e-Course 2020

Study shows LAAO reduces major bleeding and mortality compared with NOACs...

Jens Erik Nielsen-Kudsk (Aarhus, Denmark) speaks to Cardiovascular News about a propensity score-matched study which examined left atrial appendage occlusion (LAAO) compared with novel...

PCR e-Course 2020: Two-year outcomes of deferred revascularisation based on FFR...

Mid-term data continue to show non-inferiority of resting instantaneous wave-free ratio (iFR) when tested against hyperaemic fractional flow reserve (FFR), said Javier Escaned (Hospital...

PCR e-Course 2020: P2Y12 inhibitor monotherapy associated with increased risk of...

A subanalysis of the Onyx One study found that cardiac death was significantly higher in patients who received single antiplatelet therapy with a P2Y12...

PCR e-Course 2020: Roll-in trial finds high device success rate for...

Left atrial appendage occlusion (LAAO) using the Amplatzer Amulet (Abbott) device has a high implant success rate and a low procedural complication rate in...

PCR e-Course 2020: Bicuspid TAVI is feasible, safe and efficient

The feasibility, safety, and efficiency of transcatheter aortic valve implantation (TAVI) using a self-expanding platform in bicuspid aortic valves has been confirmed by the...

PCR e-Course 2020: Data for Ultimaster reinforce safety and efficacy of...

According to a press release, one-year total population clinical outcome data from e-ULTIMASTER—the world’s largest registry of patients treated with a drug-eluting stent—can reinforce...

PCR e-Course 2020: Cangrelor provided inferior inhibitor of platelet aggregation than...

The FABOLUS FASTER trial, which was presented at PCR e-Course 2020 and simultaneously published in Circulation, shows that cangrelor provides inferior inhibitor of platelet...

PCR e-Course 2020: CoFI system may address microvascular obstruction after primary...

Felice Gragnano (Inselspital, Bern University Hospital, Bern, Switzerland) outlined at PCR e-Course 2020 the initial results with the CoFlo system (CorFlow Therapeutics). He explained...

PCR e-Course 2020: Left atrial appendage occlusion improves clinical outcomes vs...

Left atrial appendage occlusion (LAAO) improves clinical outcomes including ischaemic stroke, major bleeding and all-cause mortality, in atrial fibrillation (AF) patients with a high...

PCR e-Course 2020: Routine revascularisation confers no survival advantage over initial...

Sripal Bangalore (New York University Grossman School of Medicine, New York, USA) presented the results of a late-breaking meta-analysis of randomised trials (including the...

PCR e-Course 2020: Reduction in tricuspid regurgitation with TriClip edge-to-edge repair...

One-year results from the TRILUMINATE study show that TriClip (Abbott) transcatheter therapy for symptomatic moderate or greater tricuspid regurgitation (TR) results in durable reduction...

PCR e-Course 2020: DynamX Bioadaptor shows “excellent” safety and efficacy at...

Clinical and imaging results at 12 months for the DynamX Novolimus-Eluting Coronary Bioadaptor system (Elixir Medical) have demonstrated “excellent” safety and efficacy, a late-breaking...

PCR e-Course 2020: DEFINITION II finds two-stent approach better than provisional...

A systematic two-stent approach in complex coronary bifurcation lesions is associated with a significantly greater improvement in clinical outcomes at one year than provisional...

PCR e-Course 2020: Sham patients from RADIANCE-HTN SOLO who crossed over...

Patients who crossed over from the sham control arm of the RADIANCE-HTN SOLO trial to the renal denervation arm after 12 months of elevated...

PCR e-Course 2020: Evolut Low-Risk trial confirms TAVI is non-inferior to...

Full one-year follow-up from the Evolut Low Risk trial has upheld earlier findings from the study, demonstrating that transcatheter aortic valve implantation (TAVI) is...

First evaluation of long-term outcomes after aortic valve-in-valve presented at PCR...

Long-term clinical outcomes, including mortality, following an aortic valve-in-valve procedure may be affected by the size of the original degenerated bioprosthetic valve, according to...

PCR e-Course 2020: Evoque demonstrates feasibility for mitral valve replacement via...

Use of the transseptal Evoque transmitral valve replacement (TMVR) system (Edwards Lifesciences) has been shown to be feasible in a first-in-human experience, a hotline...

PCR e-Course 2020: Mitral valve-in-valve and valve-in-ring strategies often require repeat...

A comprehensive evaluation of mitral valve-in-valve (ViV) and valve-in-ring (ViR) procedures has found that residual mitral stenosis and/or mitral regurgitation were “relatively common”, and...